VFA
CTIC

Virtus Fund Advisers’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Virtus Fund Advisers’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,145
Closed -$32K – 2741
2014
Q2 		$32K Buy
+1,145
New +$34.4K ﹤0.01% 2169

Other funds holding CTIC

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Virtus Fund Advisers's CTIC Position: Q3 2014 in Review

Virtus Fund Advisers sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q3 2014, closing a stake of 1,145 shares — an estimated $32K sold.

Virtus Fund Advisers first reported a position in CTIC in Q2 2014 and held it in 1 quarter. The position peaked at $32K in Q2 2014. 85 funds tracked by Wall St. Rank hold CTIC as of Q3 2014.

  • Virtus Fund Advisers reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 1,145 CTI BioPharma Corp. (DE) Common Stock shares in Q3 2014, an estimated $32K.
  • Virtus Fund Advisers first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's CTI BioPharma Corp. (DE) Common Stock position peaked at $32K in Q2 2014.
  • 85 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.